Pirfenidone protects against pulmonary hypertension in the Sugen5416/hypoxia rat model

P. Poble (Le Plessis-Robinson, France), C. Phan (Le Plessis-Robinson, France), T. Quatremare (Le Plessis-Robinson, France), J. Bordenave (Le Plessis-Robinson, France), R. Thuillet (Le Plessis-Robinson, France), A. Cumont (Le Plessis-Robinson, France), A. Huertas (Le Plessis-Robinson, France), P. Dorfmüller (Le Plessis-Robinson, France), L. Tu (Le Plessis-Robinson, France), M. Humbert (Le Plessis-Robinson, France), M. Ghigna (Le Plessis-Robinson, France), C. Guignabert (Le Plessis-Robinson, France)

Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Session: Risk stratification in treatment of pulmonary arterial hypertension
Session type: Oral Presentation
Number: 274
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Poble (Le Plessis-Robinson, France), C. Phan (Le Plessis-Robinson, France), T. Quatremare (Le Plessis-Robinson, France), J. Bordenave (Le Plessis-Robinson, France), R. Thuillet (Le Plessis-Robinson, France), A. Cumont (Le Plessis-Robinson, France), A. Huertas (Le Plessis-Robinson, France), P. Dorfmüller (Le Plessis-Robinson, France), L. Tu (Le Plessis-Robinson, France), M. Humbert (Le Plessis-Robinson, France), M. Ghigna (Le Plessis-Robinson, France), C. Guignabert (Le Plessis-Robinson, France). Pirfenidone protects against pulmonary hypertension in the Sugen5416/hypoxia rat model. 274

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: